Afya (NASDAQ:AFYA) Cut to Neutral at Bank of America

Bank of America cut shares of Afya (NASDAQ:AFYA) from a buy rating to a neutral rating in a report issued on Tuesday morning, MarketBeat.com reports. The brokerage currently has $17.00 target price on the stock, down from their prior target price of $22.00.

Several other analysts have also issued reports on the stock. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday, January 16th. Zacks Research cut shares of Afya from a “hold” rating to a “strong sell” rating in a report on Friday, January 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Finally, Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 31st. One analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $17.30.

Afya Stock Down 0.7%

NASDAQ:AFYA opened at $13.55 on Tuesday. Afya has a twelve month low of $13.12 and a twelve month high of $19.90. The firm has a market capitalization of $1.27 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 0.66 and a beta of 0.50. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.21. The stock’s 50 day moving average price is $14.67 and its two-hundred day moving average price is $14.87.

Hedge Funds Weigh In On Afya

Institutional investors and hedge funds have recently made changes to their positions in the company. XTX Topco Ltd bought a new position in shares of Afya during the fourth quarter worth approximately $215,000. Mangrove Partners IM LLC acquired a new position in Afya in the 4th quarter valued at $197,000. State Street Corp grew its holdings in Afya by 25.8% in the 4th quarter. State Street Corp now owns 126,914 shares of the company’s stock valued at $1,955,000 after buying an additional 26,005 shares in the last quarter. Campbell & CO Investment Adviser LLC increased its position in Afya by 45.3% during the 4th quarter. Campbell & CO Investment Adviser LLC now owns 39,683 shares of the company’s stock worth $612,000 after buying an additional 12,365 shares during the period. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Afya during the fourth quarter worth $462,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.